The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
The clinical case of the successful use of the myocardial cytoprotector trimetazidine as a universal anti-ischemic agent in a patient with hemodynamic angina due to myocardial bridging is described. The pathogenetic rationale for this prescription is presented.
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2019-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2341 |
| _version_ | 1797882401173536768 |
|---|---|
| author | O. V. Tsygankova L. D. Latyntseva T. I. Batluk D. Yu. Platonov N. M. Akhmedzhanov |
| author_facet | O. V. Tsygankova L. D. Latyntseva T. I. Batluk D. Yu. Platonov N. M. Akhmedzhanov |
| author_sort | O. V. Tsygankova |
| collection | DOAJ |
| description | The clinical case of the successful use of the myocardial cytoprotector trimetazidine as a universal anti-ischemic agent in a patient with hemodynamic angina due to myocardial bridging is described. The pathogenetic rationale for this prescription is presented. |
| first_indexed | 2024-04-10T03:35:13Z |
| format | Article |
| id | doaj.art-8544dbd9cbf5426298ee20f5f4c0f666 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:35:13Z |
| publishDate | 2019-12-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-8544dbd9cbf5426298ee20f5f4c0f6662023-03-13T07:23:28Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252019-12-0118611612010.15829/1728-8800-2019-6-116-1202019The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label useO. V. Tsygankova0L. D. Latyntseva1T. I. Batluk2D. Yu. Platonov3N. M. Akhmedzhanov4Научно-исследовательский институт терапии и профилактической медицины — филиал ФГБНУ “Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук; Новосибирский государственный медицинский университет Министерства здравоохранения Российской ФедерацииНаучно-исследовательский институт терапии и профилактической медицины — филиал ФГБНУ “Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук”Научно-исследовательский институт терапии и профилактической медицины — филиал ФГБНУ “Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук”Тверской государственный медицинский университет Министерства здравоохранения Российской ФедерацииНациональный медицинский исследовательский центр профилактической медицины Министерства здравоохранения Российской ФедерацииThe clinical case of the successful use of the myocardial cytoprotector trimetazidine as a universal anti-ischemic agent in a patient with hemodynamic angina due to myocardial bridging is described. The pathogenetic rationale for this prescription is presented.https://cardiovascular.elpub.ru/jour/article/view/2341off-label useгемодинамическая стенокардиятриметазидин |
| spellingShingle | O. V. Tsygankova L. D. Latyntseva T. I. Batluk D. Yu. Platonov N. M. Akhmedzhanov The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use Кардиоваскулярная терапия и профилактика off-label use гемодинамическая стенокардия триметазидин |
| title | The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use |
| title_full | The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use |
| title_fullStr | The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use |
| title_full_unstemmed | The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use |
| title_short | The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use |
| title_sort | use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off label use |
| topic | off-label use гемодинамическая стенокардия триметазидин |
| url | https://cardiovascular.elpub.ru/jour/article/view/2341 |
| work_keys_str_mv | AT ovtsygankova theuseofthemyocardialcytoprotectortrimetazidineinapatientwithanginaasanexampleofofflabeluse AT ldlatyntseva theuseofthemyocardialcytoprotectortrimetazidineinapatientwithanginaasanexampleofofflabeluse AT tibatluk theuseofthemyocardialcytoprotectortrimetazidineinapatientwithanginaasanexampleofofflabeluse AT dyuplatonov theuseofthemyocardialcytoprotectortrimetazidineinapatientwithanginaasanexampleofofflabeluse AT nmakhmedzhanov theuseofthemyocardialcytoprotectortrimetazidineinapatientwithanginaasanexampleofofflabeluse AT ovtsygankova useofthemyocardialcytoprotectortrimetazidineinapatientwithanginaasanexampleofofflabeluse AT ldlatyntseva useofthemyocardialcytoprotectortrimetazidineinapatientwithanginaasanexampleofofflabeluse AT tibatluk useofthemyocardialcytoprotectortrimetazidineinapatientwithanginaasanexampleofofflabeluse AT dyuplatonov useofthemyocardialcytoprotectortrimetazidineinapatientwithanginaasanexampleofofflabeluse AT nmakhmedzhanov useofthemyocardialcytoprotectortrimetazidineinapatientwithanginaasanexampleofofflabeluse |